2-Chlorodeoxyadenosine (CDA) therapy in chronic lymphocytic leukemia (CLL) and Waldenstrom's macroglobulinemia (WD): An update on 77 patients.

Maerevoet, M.; Ferrant, Augustin; Delannoy, André; Bosly, André; Martiat, P.; Mineur, P.; Canon, JL.; Zenebergh, A.; Michaux, JL.

2-Chlorodeoxyadenosine (CDA) therapy in chronic lymphocytic leukemia (CLL) and Waldenstrom's macroglobulinemia (WD): An update on 77 patients.

Maerevoet, M.

;

Ferrant, Augustin

;

Delannoy, André

;

Bosly, André

;

Michaux, JL.

;et.al.

(1995)

Files

No attached file found for this publication.

Details

Authors

Maerevoet, M.
Author
Ferrant, AugustinUCLouvain
Author
Delannoy, AndréUCLouvain
Author
Bosly, AndréUCLouvain
Author
Michaux, JL.
Author

Affiliations

UCLouvainCliniques universitaires Saint-Luc
UCLouvainMD/MINT - Département de médecine interne

Citations

APA
Chicago
FWB

Maerevoet, M., Ferrant, A., Delannoy, A., Bosly, A., Martiat, P., Mineur, P., Canon, JL., Zenebergh, A., & Michaux, JL. (1995). 2-Chlorodeoxyadenosine (CDA) therapy in chronic lymphocytic leukemia (CLL) and Waldenstrom’s macroglobulinemia (WD): An update on 77 patients. Blood, 86(10), 3338. (Original work published 1995)